Gastrointestinal Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Therapeutics Overall Market Size
2.1 Global Gastrointestinal Therapeutics Market Size: 2021 VS 2027
2.2 Global Gastrointestinal Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Therapeutics Players in Global Market
3.2 Top Global Gastrointestinal Therapeutics Companies Ranked by Revenue
3.3 Global Gastrointestinal Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gastrointestinal Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Gastrointestinal Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Gastrointestinal Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Therapeutics Market Size, 2021 & 2027
5.1.2 IBD
5.1.3 Irritable Bowel Syndrome (IBS)
5.2 By Application - Global Gastrointestinal Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Gastrointestinal Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gastrointestinal Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Gastrointestinal Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Gastrointestinal Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gastrointestinal Therapeutics Revenue, 2016-2027
6.3.2 US Gastrointestinal Therapeutics Market Size, 2016-2027
6.3.3 Canada Gastrointestinal Therapeutics Market Size, 2016-2027
6.3.4 Mexico Gastrointestinal Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Therapeutics Revenue, 2016-2027
6.4.2 Germany Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.3 France Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.4 U.K. Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.5 Italy Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.6 Russia Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Gastrointestinal Therapeutics Market Size, 2016-2027
6.4.8 Benelux Gastrointestinal Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Therapeutics Revenue, 2016-2027
6.5.2 China Gastrointestinal Therapeutics Market Size, 2016-2027
6.5.3 Japan Gastrointestinal Therapeutics Market Size, 2016-2027
6.5.4 South Korea Gastrointestinal Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Gastrointestinal Therapeutics Market Size, 2016-2027
6.5.6 India Gastrointestinal Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gastrointestinal Therapeutics Revenue, 2016-2027
6.6.2 Brazil Gastrointestinal Therapeutics Market Size, 2016-2027
6.6.3 Argentina Gastrointestinal Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Therapeutics Revenue, 2016-2027
6.7.2 Turkey Gastrointestinal Therapeutics Market Size, 2016-2027
6.7.3 Israel Gastrointestinal Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Gastrointestinal Therapeutics Market Size, 2016-2027
6.7.5 UAE Gastrointestinal Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Gastrointestinal Therapeutics Major Product Offerings
7.1.4 AbbVie Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.1.5 AbbVie Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Gastrointestinal Therapeutics Major Product Offerings
7.2.4 Allergan Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.2.5 Allergan Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Gastrointestinal Therapeutics Major Product Offerings
7.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 Takeda
7.4.1 Takeda Corporate Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Gastrointestinal Therapeutics Major Product Offerings
7.4.4 Takeda Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.4.5 Takeda Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Gastrointestinal Therapeutics Major Product Offerings
7.5.4 Novartis Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastrointestinal Therapeutics Major Product Offerings
7.6.4 Pfizer Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Gastrointestinal Therapeutics Major Product Offerings
7.4.4 Merck Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 F. Hoffmann-La Roche
7.8.1 F. Hoffmann-La Roche Corporate Summary
7.8.2 F. Hoffmann-La Roche Business Overview
7.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Major Product Offerings
7.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.8.5 F. Hoffmann-La Roche Key News
7.9 Eli Lilly
7.9.1 Eli Lilly Corporate Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Gastrointestinal Therapeutics Major Product Offerings
7.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.9.5 Eli Lilly Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Gastrointestinal Therapeutics Major Product Offerings
7.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.10.5 AstraZeneca Key News
7.11 Procter & Gamble
7.11.1 Procter & Gamble Corporate Summary
7.11.2 Procter & Gamble Business Overview
7.11.3 Procter & Gamble Gastrointestinal Therapeutics Major Product Offerings
7.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.11.5 Procter & Gamble Key News
7.12 Tillotts Pharma
7.12.1 Tillotts Pharma Corporate Summary
7.12.2 Tillotts Pharma Business Overview
7.12.3 Tillotts Pharma Gastrointestinal Therapeutics Major Product Offerings
7.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.12.5 Tillotts Pharma Key News
7.13 Takeda
7.13.1 Takeda Corporate Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Gastrointestinal Therapeutics Major Product Offerings
7.13.4 Takeda Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.13.5 Takeda Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Major Product Offerings
7.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.14.5 GlaxoSmithKline Key News
7.15 Amgen
7.15.1 Amgen Corporate Summary
7.15.2 Amgen Business Overview
7.15.3 Amgen Gastrointestinal Therapeutics Major Product Offerings
7.15.4 Amgen Gastrointestinal Therapeutics Revenue in Global (2016-2021)
7.15.5 Amgen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Gastrointestinal Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Therapeutics Market Drivers in Global Market
Table 3. Gastrointestinal Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Therapeutics in Global Market
Table 5. Top Gastrointestinal Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gastrointestinal Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gastrointestinal Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gastrointestinal Therapeutics Product Type
Table 9. List of Global Tier 1 Gastrointestinal Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Gastrointestinal Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gastrointestinal Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gastrointestinal Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Gastrointestinal Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gastrointestinal Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gastrointestinal Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Gastrointestinal Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gastrointestinal Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gastrointestinal Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gastrointestinal Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gastrointestinal Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gastrointestinal Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gastrointestinal Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gastrointestinal Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Gastrointestinal Therapeutics Product Offerings
Table 32. AbbVie Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Allergan Corporate Summary
Table 34. Allergan Gastrointestinal Therapeutics Product Offerings
Table 35. Allergan Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Gastrointestinal Therapeutics Product Offerings
Table 38. Johnson & Johnson Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Takeda Corporate Summary
Table 40. Takeda Gastrointestinal Therapeutics Product Offerings
Table 41. Takeda Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Novartis Corporate Summary
Table 43. Novartis Gastrointestinal Therapeutics Product Offerings
Table 44. Novartis Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Gastrointestinal Therapeutics Product Offerings
Table 47. Pfizer Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Merck Corporate Summary
Table 49. Merck Gastrointestinal Therapeutics Product Offerings
Table 50. Merck Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. F. Hoffmann-La Roche Corporate Summary
Table 52. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Offerings
Table 53. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Gastrointestinal Therapeutics Product Offerings
Table 56. Eli Lilly Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Gastrointestinal Therapeutics Product Offerings
Table 59. AstraZeneca Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Procter & Gamble Corporate Summary
Table 61. Procter & Gamble Gastrointestinal Therapeutics Product Offerings
Table 62. Procter & Gamble Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Tillotts Pharma Corporate Summary
Table 64. Tillotts Pharma Gastrointestinal Therapeutics Product Offerings
Table 65. Tillotts Pharma Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. Takeda Corporate Summary
Table 67. Takeda Gastrointestinal Therapeutics Product Offerings
Table 68. Takeda Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. GlaxoSmithKline Corporate Summary
Table 70. GlaxoSmithKline Gastrointestinal Therapeutics Product Offerings
Table 71. GlaxoSmithKline Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
Table 72. Amgen Corporate Summary
Table 73. Amgen Gastrointestinal Therapeutics Product Offerings
Table 74. Amgen Gastrointestinal Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Gastrointestinal Therapeutics Segment by Type
Figure 2. Gastrointestinal Therapeutics Segment by Application
Figure 3. Global Gastrointestinal Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gastrointestinal Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2020
Figure 8. By Type - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gastrointestinal Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gastrointestinal Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. AbbVie Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Allergan Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Johnson & Johnson Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Takeda Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Pfizer Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merck Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eli Lilly Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. AstraZeneca Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Procter & Gamble Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Tillotts Pharma Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Takeda Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. GlaxoSmithKline Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Amgen Gastrointestinal Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen